Varicose Vein Treatment Devices Market Size, Share and Global Trend By Treatment Type (Laser Ablation, Endovenous Ablation, Radiofrequency Ablation, Sclerotherapy, Surgical Ligation & Stripping), By Device (Ablation Devices, Radiofrequency Ablation Devices, Venous Closure Systems, Surgical Products), By End User (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs)), and Regional Forecast, 2024-2032

Varicose vein also referred to as varicoses or varicosities, is a medical condition where the veins appear as enlarged, dilated, gnarled or overfilled with blood. Any type of vein or individual is susceptible to varicose veins though the condition occurs more in females, and the part of the body most affected is the lower legs. For some individuals, varicose veins or spider vein (milder variation of varicose veins) is an aesthetic concern whereas in many cases, varicose veins are painful and causing discomfort for the individuals.

Varicose veins are often indicative of other associated comorbidities such as circulatory problems, obesity complications, and deep vein thrombosis and cause further complications such as ulcers and blood clots. Symptoms of varicose veins include veins of purple or dark blue color, veins that are bulging or twisting, aching in the legs, itching and the worsening of pain after standing or sitting for long periods. The treatment of varicose veins includes self-care through losing weight & exercising and procedures such as laser surgeries and sclerotherapy. The increasing prevalence of varicose veins and other associated factors are contributing to the positive growth of the market.

The global varicose vein treatment devices market is anticipated to grow, owing to a number of factors such as increased prevalence of varicose veins, increased incidences of obesity, increasing geriatric population pools, increased technological advancements, rising demand for preventive medical care, increasing demand for minimally invasive treatment, increasing awareness regarding varicose vein treatment and availability of new treatment options. In estimates released by the Society for Vascular Surgery (SVS), it was estimated that 20-25 million individuals in the U.S. have varicose veins and it affects 17% of males and 33% of females in the U.S. These trends combined with the other factors are expected to positively drive the market growth.

The factors limiting the growth of the global varicose vein treatment devices market includes the associated side effects of the treatment options, the dearth of training for skilled professionals, and the expensiveness of treatment options.

Key Players Covered

Some of the major companies that are present in the global varicose vein treatment devices market are Medtronic, AngioDynamics, biolitec AG, Lumenis, Syneron Medical Ltd, Dornier MedTech, Teleflex Incorporated, Quanta System S.p.A., and others.

SEGMENTATION

Among the treatment type segment, endovenous ablation is projected to hold a considerable share of the global varicose vein treatment devices market due to higher adoption of endovenous ablation due to its minimally invasive nature and association with a lesser number of complications.

Key Insights

• Regulatory scenario for key countries
• Reimbursement scenario for key countries
• Recent industry developments such as partnerships, mergers, and acquisitions
• Overview of the technological advancements
• New product launches
• Overview of the prevalence of obesity by key countries
• Overview of opportunity assessment in an untapped market

Regional Analysis

North America accounts for the largest share in the global market due to the increasing prevalence of varicose veins, a large proportion of the population suffering from obesity, established healthcare system, high medical expenditure, access to advanced treatment options and greater awareness of varicose vein treatment options. The Asia Pacific is the fastest emerging market due to increasing incidences of varicose veins, large population pools, aging population, increasing awareness of and access to advanced treatment options and increasing healthcare expenditure due to greater disposable incomes.

Key Industry Developments

• In February 2019, Medtronic announced the launch of the Accurian RF ablation system in the U.S., after the 501(k) clearance from the FDA
• In April 2018, Cardiva Medical, Inc. announced that its vascular closure system received an expanded indication for the patients undergoing the interventional cardiac catheterization procedures and is now approved for femoral venous closures
• In January 2016, Medtronic announced the launch of the OsteoCool radiofrequency ablation system in the U.S.